SAB Biotherapeutics (SABS) files $300M mixed shelf
Tweet
Share
E-mailGet Alerts SABS Hot Sheet
Join SI Premium – FREE
SAB Biotherapeutics (NASDAQ: SABS) has filed $300,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Rights
Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SEC clears registration for Inflection Point and GOWell merger
- Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
- RideNow Group, Inc. (RDNW) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
